preliminary

Pharmaceutical News BioAlliance Pharma SA today announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramyc (miconazole Lauriad), Mucoadhesive Buccal Tablets (MBT) developed for the treatment of OroPharyngeal read more »
Discuss   Add this link to...  Bury
[ logo.jpg]BioAlliance Pharma SA (Paris:BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections, in cancer and HIV, today announced the preliminary positive results for its US pivotal Phase III clinical trial wit read more »
Discuss   Add this link to...  Bury
BioAlliance Pharma SA (Paris:BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections, in cancer and HIV, announced the preliminary positive results for its US pivotal Phase III clinical trial with Loramycâ„¢ (micon read more »
Discuss   Add this link to...  Bury